Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GET Group is a biotechnology and technology company focused on developing innovative solutions in the life sciences and energy sectors. The company leverages its proprietary GET Platform to advance programs in infectious diseases and oncology, primarily at the pre-clinical stage. GET Group aims to integrate advanced engineering with biological research to create sustainable and effective therapeutic options. Their business model includes strategic partnerships and internal development to bring novel technologies to market. The company is also involved in secure identification and digital solutions, broadening its impact across multiple industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GET.